page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Cyclobenzaprine Hydrochloride (Flexeril)

Category:

  • Muscle relaxant

Description:

  • Centrally acting skeletal muscle relaxant

  Indications:

  • Skeletal muscle spasms associated with painful musculoskeletal conditions

  • Unlabeled use:

    • fibrositis syndrome: 10-40mg/day in divided doses

  Contraindications:

  • Concomitant administration with monoamine oxidase inhibitors (MAOI) or with 14 days post discontinuing MAOI use.

  • Acute recovery phase of myocardial infarction.

  • Patients with arrhythmias, heart block, or conduction disorders.

  • Patients with congestive heart failure.

  • Patients with hyperthyroidism.

 Precautions:

  • Pregnancy category B

  • Structurally related to tricyclic antidepressants.

  • Use with caution in patients with a history of urinary retention, closed-angle glaucoma and increased intraocular pressure due to possible anticholinergic effects.

  • Will impair higher order motor function, therefore use caution when operating machinery or automobiles.

  • Use for only short-term treatment (2-3 weeks).

  • Use with caution when administering with other CNS depressive medications.

  • Do not drink alcohol when using cyclobenzaprine.

  Adverse Reactions (Side Effects):

  • Central nervous system: drowsiness, dizziness, fatigue, blurred vision, headache, nervousness
  • Gastrointestinal: nausea, constipation, dyspepsia, unpleasant taste
  • Dry mouth

Dosage:

  • Administered orally (tablets, capsules, liquid) or rectally

  • Adult:

    • 20-40mg per day in divided doses (no greater than 60mg per day)

    • Do not use for periods greater than three weeks

    • Not recommended for children under 15 years old.

  • Fibrositis syndrome:

    • 10-40mg/day in divided doses

 


The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site